Mainz Biomed N.V. (BST: 4TO)
Germany
· Delayed Price · Currency is EUR 6.64
-0.10 (-1.48%)
At close: Dec 5, 2024
Mainz Biomed Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -22.51 | -26.3 | -26.39 | -11.69 | -0.59 | -0.96 |
| Depreciation & Amortization | 0.9 | 0.87 | 0.38 | 0.07 | 0.06 | 0.05 |
| Stock-Based Compensation | 2.94 | 4.01 | 9.82 | 6.43 | - | - |
| Provision & Write-off of Bad Debts | -0.02 | 0.01 | 0.07 | - | 0 | 0.02 |
| Other Operating Activities | 0.17 | -0.46 | -0.04 | 2.11 | -0 | 0.05 |
| Change in Accounts Receivable | -0.11 | 0.02 | -0.21 | 0.02 | -0.1 | 0.34 |
| Change in Inventory | -0.28 | -0.5 | -0.17 | - | - | - |
| Change in Accounts Payable | -0.16 | 0.72 | 1.65 | 0.66 | 0.16 | 0.09 |
| Change in Unearned Revenue | -0.08 | -0.06 | 0.17 | 0.01 | -0 | -0 |
| Change in Other Net Operating Assets | -0.16 | -0.24 | -0.05 | -0.83 | -0 | 0 |
| Operating Cash Flow | -19.31 | -21.94 | -14.77 | -3.22 | -0.47 | -0.42 |
| Capital Expenditures | -0.29 | -1.2 | -0.66 | -0.02 | -0.01 | - |
| Cash Acquisitions | - | - | - | 1.22 | - | - |
| Sale (Purchase) of Intangibles | -0.5 | -0.7 | - | - | - | - |
| Investing Cash Flow | -0.79 | -1.9 | -0.66 | 1.2 | -0.01 | - |
| Short-Term Debt Issued | - | - | - | 0 | 0.03 | 0 |
| Long-Term Debt Issued | - | 10.12 | - | 0.24 | 0.41 | 0.45 |
| Total Debt Issued | 8.03 | 10.12 | - | 0.25 | 0.44 | 0.45 |
| Short-Term Debt Repaid | - | - | -0.11 | - | - | - |
| Long-Term Debt Repaid | - | -2.29 | -0.2 | -0.06 | -0.04 | -0.03 |
| Total Debt Repaid | -2.46 | -2.29 | -0.3 | -0.06 | -0.04 | -0.03 |
| Net Debt Issued (Repaid) | 5.57 | 7.83 | -0.3 | 0.19 | 0.4 | 0.42 |
| Issuance of Common Stock | 5.01 | 6.39 | 24.25 | 10.43 | - | - |
| Financing Cash Flow | 10.59 | 14.23 | 23.94 | 10.61 | 0.4 | 0.42 |
| Foreign Exchange Rate Adjustments | -0.42 | -0.46 | -0.1 | 0.01 | 0 | -0.03 |
| Net Cash Flow | -9.93 | -10.07 | 8.41 | 8.6 | -0.08 | -0.03 |
| Free Cash Flow | -19.6 | -23.14 | -15.43 | -3.24 | -0.48 | -0.42 |
| Free Cash Flow Margin | -2136.98% | -2583.83% | -2911.63% | -560.67% | -96.93% | -148.01% |
| Free Cash Flow Per Share | -39.17 | -56.98 | -43.59 | -17.96 | -3.41 | -2.97 |
| Cash Interest Paid | 0.24 | 0.15 | 0.13 | 0.05 | 0.02 | 0.16 |
| Levered Free Cash Flow | -12.58 | -13.61 | -5.7 | 0.04 | - | - |
| Unlevered Free Cash Flow | -11.87 | -13.26 | -5.52 | 0.26 | - | - |
| Change in Net Working Capital | 1.15 | -0.42 | -1.46 | 0.15 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.